Extendicare, Inc.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: CA30224T8639
CAD
22.08
1.09 (5.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Extendicare, Inc. stock-summary
stock-summary
Extendicare, Inc.
Hospital
Extendicare Inc. is a Canada-based company that offers senior care across Canada. The Company’s segments include long-term care (LTC); retirement living; home health care; other Canadian operations and Remaining U.S. The long-term care segment owns and operates LTC centers, inclusive of a standalone designated supportive living center and a designated supportive living wing in Alberta, and retirement wings in Ontario. The retirement living segment owns and operates retirement living communities under the Esprit Lifestyle Communities brand. The home health care segment provides home health care services through ParaMed. The Company’s other Canadian operations are composed of its contract services and consulting provided by Extendicare Assist and its purchasing services. The Remaining U.S segment consists of its wholly owned Bermuda based captive insurance company, Laurier Indemnity Company, Ltd.
Company Coordinates stock-summary
Company Details
3000 Steeles Ave E Suite 700 , MARKHAM ON : L3R 9W2
stock-summary
Tel: 1 905 47055341 905 4705534
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Alan Torrie
Independent Chairman of the Board
Dr. Michael Guerriere
President, Chief Executive Officer, Director
Ms. Norma Beauchamp
Independent Director
Ms. Sandra Hanington
Independent Director
Mr. Alan Hibben
Independent Director
Mr. Brent Houlden
Independent Director
Ms. Donna Kingelin
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
383 Million
(Quarterly Results - Jun 2025)
Net Profit:
32 Million
stock-summary
Industry

Hospital

stock-summary
Market cap

CAD 1,354 Million (Small Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.82

stock-summary
Return on Equity

60.73%

stock-summary
Price to Book

9.09